Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation

Neurology. 2008 Jan 29;70(5):401-2. doi: 10.1212/01.wnl.0000300671.37279.0e.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Multicenter Study

MeSH terms

  • Adult
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / radiotherapy*
  • Disease Progression
  • Disease-Free Survival
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Humans
  • Kaplan-Meier Estimate
  • Lymphoma / drug therapy*
  • Lymphoma / radiotherapy*
  • Methotrexate / administration & dosage*
  • Neoplasm Recurrence, Local / drug therapy
  • Neoplasm Recurrence, Local / radiotherapy
  • Radiotherapy / methods*
  • Survival Rate
  • Time
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Methotrexate